NewLink Genetics (NLNK) Shows Strength: Stock Up 23.7% – Tale of the Tape

NewLink Genetics Corporation ( NLNK ) was a big mover last session with its shares rising nearly 24% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This reverses the recent downtrend for the company as the stock has lost nearly 13% in the past one-month time frame.

This biopharmaceutical company has seen no estimate revision in the last 30 days. The Zacks Consensus Estimate hasn't been in trend either. Yesterday's price action is encouraging though, so make sure to keep a close watch on this firm in the near future.

NewLink Genetics has a Zacks Rank #3 (Hold) and its Earnings ESP is 0.00%.

Some better-ranked biomedical stocks worth considering are Genomic Health Inc. ( GHDX ), Ligand Pharmaceuticals Inc. ( LGND ) and Halozyme Therapeutics, Inc. ( HALO ). All three stocks sport a Zacks Rank #1 (Strong Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days . Click to get this free report >>

NEWLINK GENETIC (NLNK): Free Stock Analysis Report

GENOMIC HEALTH (GHDX): Free Stock Analysis Report

LIGAND PHARMA-B (LGND): Free Stock Analysis Report

HALOZYME THERA (HALO): Free Stock Analysis Report

To read this article on Zacks.com click here.

More:
NewLink Genetics (NLNK) Shows Strength: Stock Up 23.7% - Tale of the Tape